SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have gotten us one step closer to understanding and overcoming one of the least-understood mechanisms of HIV infection—by devising a method to precisely track the life cycle of individual cells infected with HIV, the virus that causes AIDS.
SAN FRANCISCO, CA—July 23, 2012—Warner C. Greene, MD, who directs virology and immunology research at the Gladstone Institutes, has joined with other global AIDS experts to release a locally affordable version of the world’s leading AIDS medical textbook.
SAN FRANCISCO, CA—May 1, 2012—Warner C. Greene, MD, PhD, who directs virology and immunology research at the Gladstone Institutes, has been inducted as president of the Association of American Physicians (AAP).
SAN FRANCISCO, CA—April 25, 2012—Warner C. Greene, MD, PhD—who directs virology and immunology research at the Gladstone Institutes—has won the 2012 Alumni Achievement Award from the Washington University School of Medicine in St. Louis (WUSTL).
SAN FRANCISCO, CA—Gladstone Institutes scientist Nevan Krogan, PhD, today is announcing research that identifies how HIV—the virus that causes AIDS—hijacks the body's own defenses to promote infection. This discovery could one day help curb the spread of the HIV/AIDS pandemic.
SAN FRANCISCO, CA—A scientist at the Gladstone Institutes has discovered how a gene known as SIRT3 contributes to a suite of health problems sweeping across America, offering new insight into how to combat these potentially fatal conditions.
SAN FRANCISCO, CA—Scientists at Gladstone Institute of Virology and Immunology have solved a long-standing mystery about HIV infection—namely how HIV promotes the death of CD4 T cells. It is the loss of this critical subset of immune cells that leads to the development of AIDS.
San Francisco, CA—In a finding with the potential to fundamentally change strategies to slow the global HIV epidemic, a new study called iPrEx shows that individuals at high risk for HIV infection who took a single daily tablet containing two widely used HIV medications, emtricitabine and tenofov
SAN FRANCISCO, CA—Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have discovered a new agent that might inhibit the infectivity of HIV. The agent, surfen, impairs the action of a factor in semen that greatly enhances the viral infection.
SAN FRANCISCO, CA–June 25, 2009–Scientists at the Gladstone Institute of Virology and Immunology (GIVI) have found another clue that may lead to eradication of HIV from infected patients who have been on antiretroviral therapy.